Bolton, Canada

Shen Gao

USPTO Granted Patents = 7 


 

Average Co-Inventor Count = 3.1

ph-index = 3

Forward Citations = 19(Granted Patents)


Location History:

  • Brampton, CA (2010)
  • Botton, CA (2010 - 2013)
  • Bolton, CA (2012 - 2013)

Company Filing History:


Years Active: 2010-2013

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Shen Gao

Introduction

Shen Gao is a notable inventor based in Bolton, CA, recognized for his significant contributions to the pharmaceutical industry. With a total of seven patents to his name, he has developed innovative solutions that address various medical needs.

Latest Patents

One of Shen Gao's latest patents is for anti-histamine compositions and their use. This invention provides a storage-stable pharmaceutical liquid solution for oral administration, containing a pharmaceutically effective amount of an antihistamine, specifically cetirizine. The solution boasts a purity of 99% or greater by weight-based HPLC assay, with residual solvents of less than 0.5% and a total impurity of less than 0.2%. Additionally, he has developed an oral suspension of prednisolone acetate, which comprises prednisolone acetate, a pharmaceutically acceptable vehicle, and a thickening agent. This formulation aims to treat patients in need of prednisolone effectively.

Career Highlights

Shen Gao has worked with Taro Pharmaceuticals North America, Inc., where he has contributed to the development of various pharmaceutical products. His expertise in formulating stable solutions has made a significant impact on the industry.

Collaborations

Throughout his career, Shen has collaborated with professionals such as Satish Asotra and Avraham Yacobi, enhancing the quality and effectiveness of his inventions.

Conclusion

Shen Gao's innovative work in the pharmaceutical field demonstrates his commitment to improving healthcare solutions. His patents reflect a deep understanding of medicinal chemistry and a dedication to advancing therapeutic options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…